Affiliation:
1. The Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins Medical Institutions, 818 Ross Research Building, 720 Rutland Avenue, Baltimore, MD 21205;
Abstract
Field cancerization was first described in 1953 as histologically altered epithelium surrounding tumor samples taken from the upper aerodigestive tract. Since then, the term has been used to describe multiple patches of pre-malignant disease, a higher-than-expected prevalence of multiple local second primary tumors, and the presence of synchronous distant tumors within the upper aerodigestive tract. Molecular techniques such as karyotype analysis, microsatellite analysis, p53 mutation screening, and X-chromosome inactivation studies have further refined the relationship among these lesions. While there are differences in the techniques used to identify the clonal origins of the lesions, these studies indicate that there is often lateral clonal spread of pre-malignant or malignant disease, and a significant portion of local second primary tumors are in fact genetically related. Distant second primary tumors found in the esophagus are often not related to concurrent head and neck cancer, whereas synchronous squamous lung tumors with a head and neck primary are often, in fact, metastases, rather than independently arising malignancies. These observations help to explain the high incidence of recurrent disease, despite excision or other therapy—pre-malignant or malignant clones often have the ability to migrate and persist outside of the field of treatment. Therefore, alternative means of prevention or therapy that can affect the entire head and neck region may be of benefit to such patients. Future studies will further refine the relationship among these lesions and perhaps identify key molecular alterations to be used as targets for gene therapy.
Subject
General Dentistry,Otorhinolaryngology
Reference42 articles.
1. Chromosomal Aneuploidy Precedes Morphological Changes and Supports Multifocality in Head and Neck Lesions
2. Chemoprevention of Head and Neck Cancer
3. Bedi GC, Westra WH, Gabrielson E, Koch W, Sidransky D (1996). Multiple head and neck tumors: evidence for a common clonal origin. Cancer Res 56:2484–2487.
4. Methodology for Evaluating the Incidence of Second Primary Cancers with Application to Smoking-relted Cancers from the Surveillance, Epidmiology, and End Results (SEER) Program
5. Boyle JO, Hakim J, Koch W, van der Riet P, Hruban RH, Roa RA, et al. (1993). The incidence of p53 mutations increases with progression of head and neck cancer. Cancer Res 53:4477–4480.
Cited by
149 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献